A CLINICAL STUDY ON TRACHOMA & ITS MANAGEMENT WITH HARITAKYADI EYE DROPS
DOI:
https://doi.org/10.70066/jahm.v1i6.118Keywords:
Pothaki, trachoma, haritakyadi eye dropsAbstract
Background: pothaki is one amongst the diseases of lid having multiple follicles resembling red mustard seeds or white mustard seeds, associated with itching, discharge, heaviness in lids etc. Its clinical features closely resemble the trachoma. Trachoma is a specific communicable keratoconjunctivitis usually of chronic in nature caused by the Chlamydia trachomatis, characterized by formation of follicles, papillary hyperplasia and pannus etc.
Aims and objectives: To evaluate the local effect of the haritakyadi eye drops on sign & symptoms and to compare the effect of trial drug and ofloxacin eye drop on the clinical features of trachoma
Methods and materials: The present clinical study was done on 118 patients of trachoma. A haritakyadi eye drop was instilled in group- A, ofloxacin in group - B as a standard control. After enrollment of the patients in the study, vital signs and symptoms of pothaki -trachoma were studied before and after the treatment. Amongst the registered patients 52 patients completed the course of treatment in each group
Results: In group – A, 36.53% patients were got marked improvement and 63.46% patients were moderately improved where as in group - B59.61%patients were got marked improvement, and 40.38% patients were moderately improved.
Conclusion: The haritakyadi eye drop has not showed any side effects as observed through the course of treatment which indicates that the drug is safe in the management of trachoma
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 NARAYAN BAVALATTI
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
